Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Oh me, oh my, the sky is falling...

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Aug 06, 2024 12:36pm

298 Views

Post# 36166120

RE:RE:RE:RE:RE:RE:RE:RE:RE:Oh me, oh my, the sky is falling...

Hi DJDawg - Yes, it looks like they are releasing the 2Q financials 4 weeks earlier than usual. But earlier this year they also released the 2023 financials a month earlier than usual. They were released at the end of March when they usually come out at the end of April.